Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
Introduction: The mTOR pathway and dopamine receptors are potential targets for treatment of neuroendocrine tumors (NET).
Conference: 11th Annual ENETSConcerence (2014)
Presenting Author: Sarnataro M
Authors: Sarnataro M, Pivonello C, De Martino M, Sciammarella C, Cuomo G,
Introduction: The mammalian target of rapamycin (mTOR) is a protein kinase involved in the control of cancer cell metabolism, growth and proliferation. The mTOR pathway has attracted broad scientific and clinical interest, particularly in light of the ongoing clinical cancer trials with mTOR inhibitors in pts with neuroendocrine tumors (NETs). To identify the best candidates for treatment with mTOR inhibitors is challenging.
Conference: 10th Annual ENETSConcerence (2013)
Presenting Author:
Authors: Sciammarella C, Pivonello C, Sarnataro M, Marotta V, Ramundo V,
Keywords: mTOR pathway, everolimus, pancreatic NET, bronchial carcinoids,
Introduction: The mTOR inhibitor rapamycin (RAP) has been considered an anticancer agent. The role of dopamine and somatostatin in controlling cell secretion and proliferation in neuroendocrine tumors (NETs) is still unclear.
Conference: 9th Annual ENETSConcerence (2012)
Presenting Author:
Authors: Pivonello R, Sarnataro M, Cariati F, Pivonello C, Colao A,
Keywords: neuroendocrine tumor, mTOR inhibitors, dopamine agonists, somatostatin analogues,